Company: ADPT
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030913
Chunk: 243

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-03-03
Form: 10-K
Item: Item 8
Chunk 243
---
 notes are an integral part of these consolidated financial statements.

92

Adaptive Biotechnologies Corporation

Consolidated Statements of Comprehensive Loss

(in thousands)

    Year Ended December 31,

    2024

    2023

    2022

    Net loss
     
    $
    (159,595
    )
     
    $
    (225,304
    )
     
    $
    (200,368
    )

    Other comprehensive (loss) income

    Change in unrealized gains and losses on investments

    (49
    )

    4,331

    (2,979
    )

    Comprehensive loss

    (159,644
    )

    (220,973
    )

    (203,347
    )

    Add: Comprehensive loss attributable to noncontrolling interest

    103

    54

    177

    Comprehensive loss attributable to Adaptive Biotechnologies Corporation
     
    $
    (159,541
    )
     
    $
    (220,919
    )
     
    $
    (203,170
    )

The accompanying notes are an integral part of these consolidated financial statements.

93

Adaptive Biotechnologies Corporation

Consolidated Statements of Shareholders’ Equity

(in thousands, except share amounts)

    Common Stock

    AdditionalPaid-In

    AccumulatedOtherComprehensive

    Accumulated

    Noncontrolling

    TotalShareholders’

    Shares

    Amount

    Capital

    (Loss) Gain

    Deficit

    Interest

    Equity

    Balance at December 31, 2021

    141,393,865

    $
    14

    $
    1,324,006

    $
    (1,137
    )
     
    $
    (718,891
    )
     
    $
    110

    $
    604,102

    Issuance of common stock for cash upon exercise of stock options

    1,406,500

    —

    7,866

    —

    —

    —

    7,866

    Vesting of restricted stock units

    304,637

    —

    —

    —

    —

    —

    —

    Share-based compensation

    —

    —

    55,477

    —

    —

    —

    55,477

    Other comprehensive loss

    —

    —

    —

    (2,979